Phase II escalation study of sorafenib in patients with metastatic renal cell carcinoma who have been previously treated with anti-angiogenic treatment.

Autor: Mancuso, Andrea1, Di Paola, Eugenio Donato1, Leone, Alvaro2, Catalano, Alfonso3, Calabrò, Fabio1, Cerbone, Linda1, Zivi, Andrea1, Messina, Carlo1, Alonso, Silvia1, Vigna, Leonardo1, Caristo, Rita1, Sternberg, Cora N.1
Zdroj: BJU International. Jan2012, Vol. 109 Issue 2, p200-206. 7p. 1 Diagram, 1 Chart.
Databáze: Academic Search Ultimate